Cargando…
82例伴Coombs试验阳性血细胞减少患者临床特征及预后分析
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295625/ https://www.ncbi.nlm.nih.gov/pubmed/34384162 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.015 |
| _version_ | 1783725471238717440 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8295625 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82956252021-08-23 82例伴Coombs试验阳性血细胞减少患者临床特征及预后分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2021-06 /pmc/articles/PMC8295625/ /pubmed/34384162 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.015 Text en 2021年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 短篇论著 82例伴Coombs试验阳性血细胞减少患者临床特征及预后分析 |
| title | 82例伴Coombs试验阳性血细胞减少患者临床特征及预后分析 |
| title_full | 82例伴Coombs试验阳性血细胞减少患者临床特征及预后分析 |
| title_fullStr | 82例伴Coombs试验阳性血细胞减少患者临床特征及预后分析 |
| title_full_unstemmed | 82例伴Coombs试验阳性血细胞减少患者临床特征及预后分析 |
| title_short | 82例伴Coombs试验阳性血细胞减少患者临床特征及预后分析 |
| title_sort | 82例伴coombs试验阳性血细胞减少患者临床特征及预后分析 |
| topic | 短篇论著 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295625/ https://www.ncbi.nlm.nih.gov/pubmed/34384162 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.015 |
| work_keys_str_mv | AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī AT 82lìbàncoombsshìyànyángxìngxuèxìbāojiǎnshǎohuànzhělínchuángtèzhēngjíyùhòufēnxī |